ACTIVE

ELYSIA

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result129,1 k €+120,8 %over 1 year

Revenue12,5 M €+21,8 %over 1 year

Equity3,6 M €+3,7 %over 1 year

Workforce25,0 ETP-2,3 %over 1 year

Identity

Source · BCE/KBO

ELYSIA is a Public limited company incorporated in 2014. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Seraing. It employs on average 25,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0551.891.891
Incorporation: 02/05/2014
Legal form: Public limited company
Registered office: Rue du Bois St-Jean 23
4102 Seraing · WallonieSee on map
Contributed capital: 4 794 800,00 €
Latest accounts: 30/06/2025
Average workforce: 25,0 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 74909Other professional, scientific and technical activities n.e.c.74999Other professional, scientific and technical activities n.e.c.27900Manufacture of other electrical equipment 27900Manufacture of other electrical equipment

Joint committees (2)

Contacts

2 public details availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 12 filings

Trend over 11 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	12,5 M €	+21.8%	10,2 M €	+11.9%	9,2 M €	+24.2%	7,4 M €	+12.4%	6,6 M €
EBITDA	962,1 k €	+541%	150 k €	-76.2%	630,8 k €	-34.9%	969 k €	+69.3%	572,3 k €
Operating result	268,2 k €	+156%	-476 k €	-3953%	12,4 k €	-96.0%	312,4 k €	+420%	-97,5 k €
Net result	129,1 k €	+121%	-619,1 k €	-10293%	-6 k €	-102%	279,5 k €	+707%	-46 k €
Balance sheet
Equity	3,6 M €	+3.7%	3,4 M €	-11.4%	3,9 M €	-0.2%	3,9 M €	+7.7%	3,6 M €
Total assets	8 M €	-5.1%	8,4 M €	+34.3%	6,3 M €	-12.6%	7,2 M €	+17.9%	6,1 M €
Cash	231,6 k €	-10.1%	257,6 k €	-26.7%	351,6 k €	-66.7%	1,1 M €	+16.1%	907,9 k €
Debts	3,9 M €	-14.1%	4,6 M €	+121%	2,1 M €	-26.7%	2,8 M €	+19.7%	2,4 M €
Other
Workforce	25,0 ETP	-2.3%	25,6 ETP	+13.3%	22,6 ETP	+10.2%	20,5 ETP	+10.2%	18,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

7 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
INVENTURES0836.671.025Represented by Olivier DE DUVE	Director03/06/2021 → 03/06/2027
NOMAINVEST0460.996.458Represented by BERNARD JOLLY	Director03/06/2021 → 03/06/2027
ANDRE LUXEN	Chairman of the board of directors28/04/2015 → 11/11/2025
BIO-CONSULT0546.980.129Represented by DANIEL BARTHOLEMY	Director28/04/2015 → 11/12/2025
BIOINNOVAS SARepresented by JORG SCHLEGEL	Director28/04/2015 → 11/11/2025
NOSHAQ PARTNERS0808.219.836Represented by FRANCOISE LEBLANC	Director28/04/2015 → 11/11/2025
XOVELIS0892.497.790Represented by FRANCOIS MOONEN	Managing director28/04/2015 → 11/11/2025

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
RETHIOS0562.943.359Represented by ERIC JANVIER	Director20/11/2015 → 2019 accounts
NOTGER INVEST0546.726.642Represented by KAMRAN GHASSEMPOUR	Director28/04/2015 → 2019 accounts

Other companies at this address

Rue du Bois St-Jean 23 4102 Seraing

Company	CBE no.
EAGLE HOLDING● Active	1040.465.055

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/11/2025	18/11/2024	17/01/2024	29/12/2022	30/11/2021	20/09/2021
General meeting	12/11/2025	12/11/2024	14/11/2023	08/11/2022	09/11/2021	10/11/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 12 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	12/11/2025	28/11/2025	French	PDF
Abridged model	30/06/2024	12/11/2024	18/11/2024	French	PDF
Abridged model	30/06/2023	14/11/2023	17/01/2024	French	PDF
Abridged model	30/06/2022	08/11/2022	29/12/2022	French	PDF
Abridged model	30/06/2021	09/11/2021	30/11/2021	French	PDF
Abridged modelCorrection	30/06/2020	10/11/2020	20/09/2021	French	PDF
Abridged model	30/06/2020	10/11/2020	14/01/2021	French	PDF
Abridged model	30/06/2019	12/11/2019	28/11/2019	French	PDF
Abridged model	30/06/2018	13/11/2018	22/11/2018	French	PDF
Abridged model	30/06/2017	14/11/2017	19/12/2017	French	PDF
Abridged model	30/06/2016	08/11/2016	19/01/2017	French	PDF
Abridged model	30/06/2015	10/11/2015	13/01/2016	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

7 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
INVENTURES0836.671.025Represented by Olivier DE DUVE	Director03/06/2021 → 03/06/2027
NOMAINVEST0460.996.458Represented by BERNARD JOLLY	Director03/06/2021 → 03/06/2027
ANDRE LUXEN	Chairman of the board of directors28/04/2015 → 11/11/2025
BIO-CONSULT0546.980.129Represented by DANIEL BARTHOLEMY	Director28/04/2015 → 11/12/2025
BIOINNOVAS SARepresented by JORG SCHLEGEL	Director28/04/2015 → 11/11/2025
NOSHAQ PARTNERS0808.219.836Represented by FRANCOISE LEBLANC	Director28/04/2015 → 11/11/2025
XOVELIS0892.497.790Represented by FRANCOIS MOONEN	Managing director28/04/2015 → 11/11/2025

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
RETHIOS0562.943.359Represented by ERIC JANVIER	Director20/11/2015 → 2019 accounts
NOTGER INVEST0546.726.642Represented by KAMRAN GHASSEMPOUR	Director28/04/2015 → 2019 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates11/09/2026
Démission et nomination administrateurs
PDF
Mandates09/02/2026
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates20/11/2025
DEMISSIONS, NOMINATIONS
PDF
Capital / shares18/04/2024
CAPITAL, ACTIONS
PDF
Mandates21/03/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates23/12/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates07/06/2021
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Capital / shares13/01/2021
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings11 filings

Mandates

NOMAINVEST

INVENTURES

BIO-CONSULT

NOSHAQ PARTNERS

XOVELIS

BIOINNOVAS SA

ANDRE LUXEN

RETHIOS

NOTGER INVEST

OLISA

20142015201620172018201920202021202220232024202520262027

ELYSIA

Rue du Sart-Tilman 375, 4031 Angleur

Director

Managing director

Director

Chairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue du Bois St-Jean 23, 4102 OugréeCurrent		CBE
Rue du Sart-Tilman 375, 4031 Angleur	accounts 2022 → 2025	Accounts 2025 · 2025-00578005

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
ELYSIACurrent	accounts 2022 → 2025	Accounts 2025 · 2025-00578005

Events

2025
Annual accounts 2025129,1 k €↑
2024
Annual accounts 2024-619,1 k €↓
2023
Annual accounts 2023-6 k €↓
2022
Annual accounts 2022279,5 k €↑
2021
Annual accounts 2021-46 k €↑
2020
Annual accounts 2020-155,2 k €↑
2019
Annual accounts 2019-355,7 k €↓
2018
Annual accounts 2018-344,2 k €↓
2017
Annual accounts 201763,9 k €↑
2016
Annual accounts 2016-38,7 k €↑
2015
Annual accounts 2015-127,2 k €
02/05/2014
IncorporationPublic limited company

ELYSIA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events